15 Apr ‘This opioid crisis has become a fentanyl crisis’
The opioid crisis has become increasingly worse over the last decade and is estimated to cost the U.S. government nearly $38 billion in lost tax revenue due to employment loss.Opiant Pharmaceuticals (OPNT), the company behind the overdose reversal drug Narcan, is in the process of developing nasal nalmefene, a drug...